EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.18.1.6 | Neoplasms |
14614330 |
Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2. |
unassigned |
0 |
1.18.1.6 | Optic Atrophy |
29040572 |
Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy. |
causal interaction unassigned |
3 0 |
1.18.1.6 | Optic Atrophy |
29554255 |
Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy. |
causal interaction unassigned |
3 0 |
1.18.1.6 | Iron Overload |
22101253 |
Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. |
unassigned |
0 |
1.18.1.6 | Neoplasms |
19004824 |
Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. |
unassigned |
0 |
1.18.1.6 | Colorectal Neoplasms |
11590433 |
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. |
diagnostic usage unassigned |
1 0 |
1.18.1.6 | Neoplasms |
28747430 |
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. |
causal interaction unassigned |
3 0 |
1.18.1.6 | Carcinoma |
26637858 |
Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma. |
causal interaction diagnostic usage therapeutic application unassigned |
1 1 4 0 |
1.18.1.6 | Esophageal Squamous Cell Carcinoma |
26637858 |
Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma. |
causal interaction diagnostic usage therapeutic application unassigned |
1 1 4 0 |
1.18.1.6 | Neoplasms |
34090862 |
Ferredoxin reductase regulates proliferation, differentiation, cell cycle and lipogenesis but not apoptosis in SZ95 sebocytes. |
unassigned |
0 |